Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of pegfilgrastim versus filgrastim on neutrophil counts in chemotherapy-treated cancer patients
IRCT20180119038433N3Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of pegfilgrastim and filgrastim in chemotherapy-induced neutropenia (CIN) (2 arms), sponsored by Semnan University of Medical Sciences. Started Oct 2020; status: completed.
02
Drugs
pegfilgrastimfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on IRCT20180119038433N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180119038433N3.